V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016800 | 270009867 | 1.59 | 70 | Adjuvant (A) | 2015-06-20 | 2015-06-20 | Bevacizumab 7.5mg/kg | 02 | N | 270017112 | VINBLASTINE |
| 270016801 | 270014619 | null | 60 | Adjuvant (A) | 2018-11-06 | 2019-02-04 | IVE | 02 | N | 270017117 | IVE |
| 270016802 | 270009875 | null | 73.3 | Not known (9) | 2017-05-11 | 2017-05-11 | ABVD R | N | N | 270017120 | ABVD R |
| 270016803 | 270009876 | 1.71 | 78.4 | Adjuvant (A) | 2015-04-15 | 2015-11-04 | Panitumumab | N | N | 270017123 | NIVOLUMAB |
| 270016804 | 270009879 | 1.85 | 85.6 | Curative (C) | 2016-05-14 | 2016-06-02 | Cyclophosphamide High Dose | null | N | 270017136 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016805 | 270009882 | 1.75 | 76.2 | Neo-adjuvant (N) | 2014-06-25 | 2014-08-28 | Cyclophosphamide High Dose | 02 | N | 270017162 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016806 | 270014622 | 1.89 | 83 | Palliative (P) | 2015-06-03 | 2015-06-11 | GEM-P | 2 | null | 270017167 | GEMCITABINE + PACLITAXEL |
| 270016807 | 270014622 | 1.9 | 67.7 | Curative (C) | 2018-09-20 | 2018-11-14 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 270017167 | PANITUMUMAB |
| 270016808 | 270014623 | 1.72 | 83.5 | Palliative (P) | 2017-08-20 | 2017-09-17 | Panitumumab | 02 | N | 270017169 | VEPEMB |
| 270016809 | 270018463 | 1.78 | 60.2 | null | null | 2015-01-28 | Carboplatin AUC 6 - 10 | null | N | 270017182 | NIVOLUMAB |
| 270016810 | 270009887 | 1.58 | 68.5 | Not known (9) | null | 2013-10-08 | Cetuximab + Oxaliplatin + MdG Maint | N | N | 270017186 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016811 | 270009890 | 0 | null | Palliative (P) | 2016-10-27 | 2016-10-27 | GEM-P | 02 | null | 270017187 | GEMCITABINE + PACLITAXEL |
| 270016812 | 270014626 | null | 59.9 | Palliative (P) | 2015-05-28 | 2015-05-29 | Bendamustine +/- Prednisolone | 02 | N | 270017195 | BENDAMUSTINE |
| 270016813 | 270009891 | 1.72 | 87 | Neo-adjuvant (N) | 2017-08-17 | 2017-10-05 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | 270017195 | CISPLATIN + GEMCITABINE |
| 270016814 | 270009896 | 1.78 | 83.8 | Curative (C) | null | 2015-07-11 | IVE | null | null | 270017209 | IVE |
| 270016815 | 270009899 | null | 73.2 | Neo-adjuvant (N) | 2019-02-19 | 2019-02-19 | BEAM + Alemtuzumab Allo SCT | N | N | 270017211 | CISPLATIN |
| 270016816 | 270009902 | null | 60.2 | Curative (C) | 2016-07-22 | 2016-07-22 | NIVOLUMAB | 02 | N | 270017229 | NIVOLUMAB |
| 270016817 | 270009903 | 1.73 | 96.1 | Palliative (P) | 2014-02-14 | 2014-03-01 | IGEV | N | N | 270017233 | VEPEMB |
| 270016818 | 270017077 | 1.43 | null | Curative (C) | 2015-08-15 | 2015-09-22 | Cisplatin | null | null | 270017234 | VEPEMB |
| 270016819 | 270009908 | 1.79 | null | Palliative (P) | 2016-10-21 | 2016-10-24 | Bevacizumab | N | null | 270017242 | OXALIPLATIN + RALTITREXED |
| 270016820 | 270009909 | 1.86 | 92 | Curative (C) | null | 2018-04-23 | Cyclophosphamide High Dose | null | Y | 270017244 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016821 | 270009911 | 1.69 | 63 | Curative (C) | 2018-01-20 | 2018-02-08 | VEPEMB | N | N | 270017246 | BEVACIZUMAB |
| 270016822 | 270014636 | 0 | 77.4 | Disease modification (D) | 2014-06-23 | 2014-07-23 | BEAM + Alemtuzumab Allo SCT | N | N | 270017248 | BEVACIZUMAB |
| 270016823 | 270014637 | 1.79 | 47 | Curative (C) | 2015-11-17 | 2015-12-26 | Carboplatin AUC 6 - 10 | N | N | 270017249 | CISPLATIN |
| 270016824 | 270009917 | 1.68 | null | Neo-adjuvant (N) | 2013-06-15 | 2013-06-27 | CARBOPLATIN | N | N | 270017255 | NIVOLUMAB |
| 270016825 | 270017079 | null | 89.3 | Neo-adjuvant (N) | 2013-05-21 | 2013-07-24 | Carboplatin AUC 2 - 5 | N | N | 270017260 | CISPLATIN + GEMCITABINE |
| 270016826 | 270009924 | null | 75.6 | Neo-adjuvant (N) | 2015-10-23 | 2015-11-13 | Bevacizumab | N | N | 270017261 | NIVOLUMAB |
| 270016827 | 270009928 | 1.8 | 59 | Curative (C) | 2014-03-25 | 2014-05-06 | Cisplatin 7 day | 2 | N | 270017264 | ABVD R |
| 270016828 | 270014642 | 1.65 | 71.24 | Curative (C) | null | 2017-05-07 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | 02 | Y | 270017269 | BEVACIZUMAB |
| 270016829 | 270009932 | 1.65 | null | Curative (C) | 2014-10-02 | 2014-10-04 | Cyclophosphamide High Dose | N | N | 270017276 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016830 | 270009934 | 1.43 | 110.6 | Curative (C) | 2014-12-03 | 2014-12-03 | Cisplatin+Gemcitabine (Days 1&8&15) | 02 | N | 270017276 | VEPEMB |
| 270016831 | 270009935 | 1.75 | 70 | Curative (C) | 2012-04-15 | 2014-02-01 | GDP | N | N | 270017287 | GDP |
| 270016832 | 270009943 | 1.7 | 76.8 | Curative (C) | 2015-05-28 | 2015-09-02 | BENDAMUSTINE | N | N | 270017292 | BENDAMUSTINE |
| 270016833 | 270009945 | 1.58 | 85.5 | Palliative (P) | 2015-04-08 | 2015-05-07 | Irinotecan 14day | 2 | N | 270017293 | IRINOTECAN |
| 270016834 | 270014650 | 1.7 | 81 | Curative (C) | 2015-07-14 | 2015-12-16 | Panitumumab | N | null | 270017301 | CISPLATIN |
| 270016835 | 270009951 | null | 73 | Curative (C) | 2016-12-11 | 2016-12-11 | Carboplatin AUC 2 - 5 | N | null | 270017306 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016836 | 270014652 | 1.63 | 85 | Curative (C) | 2017-09-30 | 2017-10-16 | Carboplatin AUC 2 - 5 | null | null | 270017311 | CARBOPLATIN |
| 270016837 | 270009958 | 1.59 | 76.6 | Curative (C) | 2014-09-11 | 2014-11-21 | BEAM + Alemtuzumab Allo SCT | N | N | 270017315 | GEMCITABINE |
| 270016838 | 270009962 | 1.75 | 89 | Curative (C) | null | 2015-06-16 | Panitumumab | Y | N | 270017328 | IGEV |
| 270016839 | 270014656 | null | null | Curative (C) | 2017-02-23 | 2017-02-23 | Bevacizumab | null | null | 270017330 | GEMCITABINE |
| 270016840 | 270009972 | 1.72 | 95.6 | Curative (C) | 2015-01-21 | 2015-01-27 | Cyclophosphamide High Dose | N | N | 270017331 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270016841 | 270009973 | 1.75 | 74.5 | Palliative (P) | 2016-05-01 | 2016-05-01 | GEM-P | 2 | N | 270017331 | GEMCITABINE + PACLITAXEL |
| 270016842 | 270009976 | null | 101 | null | 2017-05-23 | 2017-06-03 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 270017346 | IGEV |
| 270016843 | 270009979 | null | 57 | Curative (C) | 2016-10-17 | 2016-10-19 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270017351 | NIVOLUMAB |
| 270016844 | 270009981 | 1.6 | 75.8 | Curative (C) | 2016-11-09 | 2018-09-06 | Irinotecan 14day | 2 | N | 270017361 | IRINOTECAN |
| 270016845 | 270017091 | 1.69 | 29.2 | Palliative (P) | 2016-11-30 | 2016-12-13 | IVE | null | null | 270017363 | IVE |
| 270016846 | 270009984 | 1.73 | 83 | null | null | 2016-04-12 | BEAM + Alemtuzumab Allo SCT | null | null | 270017366 | NIVOLUMAB |
| 270016847 | 270014664 | 1.78 | 95 | Curative (C) | 2016-07-20 | 2016-07-20 | GEM-P | N | N | 270017368 | GEMCITABINE + PACLITAXEL |
| 270016848 | 270009986 | null | 56 | Curative (C) | 2017-04-28 | 2017-04-28 | Irinotecan | 2 | N | 270017379 | IRINOTECAN |
| 270016849 | 270009988 | 1.64 | 76.2 | Curative (C) | 2015-01-04 | 2015-06-05 | Cyclophosphamide High Dose | N | N | 270017381 | CYCLOPHOSPHAMIDE HIGH DOSE |